1h Free Analyst Time
The emerging molecular diagnostics market is forecasted to grow by USD 3.80 billion during 2024-2029, accelerating at a CAGR of 6.4% during the forecast period. The report on the emerging molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by prevalence of chronic diseases, increasing global geriatric population, and rising prevalence of neurological disorders.
The emerging molecular diagnostics market is segmented as below:
By Technology
- PCR
- NGS
- Microarray technologies
- Others
By End-user
- Hospitals and clinics
- Diagnostics laboratories
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the emerging molecular diagnostics market covers the following areas:
- Emerging Molecular Diagnostics Market sizing
- Emerging Molecular Diagnostics Market forecast
- Emerging Molecular Diagnostics Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Technology
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global emerging molecular diagnostics market: Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Danaher Corp., ELITechGroup SAS, F. Hoffmann La Roche Ltd., Freenome Holdings Inc, GRAIL Inc, Hologic Inc., Invitae Corp., Natera Inc., OmniScience, Paragonix Technologies Inc., Siemens Healthineers AG, Solone Life Sciences India Pvt. Ltd., Thermo Fisher Scientific Inc., U Gen Biotechnology Inc., and Veracyte Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is product launches associated with emerging molecular diagnostics."
According to the report, one of the major drivers for this market is the prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- BioMerieux SA
- Danaher Corp.
- ELITechGroup SAS
- F. Hoffmann La Roche Ltd.
- Freenome Holdings Inc
- GRAIL Inc
- Hologic Inc.
- Invitae Corp.
- Natera Inc.
- OmniScience
- Paragonix Technologies Inc.
- Siemens Healthineers AG
- Solone Life Sciences India Pvt. Ltd.
- Thermo Fisher Scientific Inc.
- U Gen Biotechnology Inc.
- Veracyte Inc.
